Boston Type I Keratoprosthesis: Antibacterial Resistance and Microbiota Evaluation of Soft Contact Lenses

Abstract

We read with great interest the article by Torres-Netto and associates titled “Boston Type I Keratoprosthesis: Antibacterial Resistance and Microbiota Evaluation of Soft Contact Lenses.” 1 Torres-Netto E.A. Silva L.D. Bordon Riveros M.A. Santos A. Sousa L.B. Oliveira L.A. Boston type I keratoprosthesis: antibacterial resistance and microbiota evaluation of soft contact lenses. Am J Ophthalmol. 2018; 192: 178-183 Scopus (4) Google Scholar Infections after Boston keratoprosthesis are devastating, and any evidence of an antibacterial resistance pattern in this field will be an essential addition to the existing literature. Boston Type I Keratoprosthesis: Antibacterial Resistance and Microbiota Evaluation of Soft Contact LensesAmerican Journal of OphthalmologyVol. 192PreviewTo evaluate microbiota colonizing soft contact lenses (CL) in eyes with Boston type I keratoprosthesis (BKPro), and determine the prevalence of resistance to fourth-generation fluoroquinolone (FQ). Full-Text PDF ReplyAmerican Journal of OphthalmologyVol. 198PreviewWe read with interest the comments about our article by Sahay and associates.1 We agree with the authors that it is not appropriate to attribute the development of antibiotic resistance to povidone-iodine (PI). While we understand the authors' concern, their interpretation must be analyzed with discretion. Even though in the discussion of our article it is clear that resistance was probably attributed to fourth-generation fluoroquinolone, it is necessary to disclose that all patients used a prophylactic regimen that not only included antibiotic therapy, but also PI. Full-Text PDF